%PDF-1.4
%
1 0 obj
<>stream
application/pdf
10.1080/14656566.2018.1544244
en
Roflumilast in patients with advanced chronic obstructive pulmonary disease: towards a better-targeted use
Ioana Alexa
Teodora Alexa-Stratulat
Sabina Antoniu
Ileana Antohe
Oana Arghir
Cristina Grigorescu
Taylor & Francis
Expert Opinion on Pharmacotherapy, 2019. doi:10.1080/14656566.2018.1544244
Chronic bronchitis
COPD
exacerbations
eosinophil
roflumilast
prognosis
Journal
Expert Opinion on Pharmacotherapy
© 2018 Informa UK Limited, trading as Taylor & Francis Group
1465-6566
1744-7666
00
00
1
3
10.1080/14656566.2018.1544244
https://doi.org/10.1080/14656566.2018.1544244
VoR
2018-11-20T03:03:21+05:30
Arbortext Advanced Print Publisher 11.0.3433/W Unicode
2018-11-22T07:47:48-08:00
2018-11-22T07:47:48-08:00
Chronic bronchitis; COPD; exacerbations; eosinophil; roflumilast; prognosis
iText 4.2.0 by 1T3XT
uuid:1441b20b-4da8-4eee-bd95-7ad5159968d7
uuid:f464f512-9ce0-441d-a6cc-a4eacb582b9a
2018-11-21truewww.tandfonline.com10.1080/14656566.2018.1544244www.tandfonline.comtrue2018-11-2110.1080/14656566.2018.1544244
endstream
endobj
4 0 obj
<>stream
xYK5ϯqn?$4[`%QN@r$"%Zۏr=?Wy?8^%A@lg~?]NM5Or(`O.e1bl|?;K{\˃I(\gwѫoZI$o5e==LLD/4ht8͡y}wyaRKgWkrDS[Dz2>ȹ=N̙}?D=ܾ$
wB[hdh|5W{K˯%&%O"k:oOדSzy&p&
K<?aƧ0?<9r\psqq`#.h~-x3KY-RO!,8e_}/\5kED\MJRl^9V
-Ŗ
`A"7˩[ߤvmra|4[t=ٹCwDž-Sy@B~($y(\@3F, /G{_Ut:u*Bg46tzhA~M;)Q=yGByTdGc6A*N(5U0K7i z!@#0'H~`߭hVßƀԤuɀ{^껳~Q~%둧k9khg:[k;~Zu_߉4GO^'܁Ol/OcRB9L8p9L3!Y-Żè?d79}Ë&ȺU}fmǏ0#|-j$Eh)Ñlz˴w:#BKx.y`iLH(-?.tm2iW'=B˒@`*?jz)GlN|hZW)2+*|zѢ\䝇{5[P#'G_Sf9s:F}!5
u/q.QѶjUnZ閌b5M.27w6Z
z;!/^djEVp^,%U|